scPharmaceuticals to Participate in Two Upcoming Investor Conferences
scPharmaceuticals Inc. (Nasdaq: SCPH) announced that John Tucker, president & CEO, will participate virtually in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
scPharmaceuticals Inc. (Nasdaq: SCPH) announced that John Tucker, president & CEO, will participate virtually in two upcoming investor conferences. The first event is the 11th Annual LifeSci Partners Corporate Access Event 2022, scheduled for January 5-7, 2022. Attendees can register and request one-on-one meetings via the provided link. The second event is the H.C. Wainwright Virtual BioConnect 2022 Conference, taking place from January 10-13, 2022, with a webcast available on-demand starting January 10 at 7am EST.
Details
News Market Reaction – SCPH
The recorded move for SCPH in the trading session of this news was +7.77%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, will participate virtually in two upcoming investor conferences.
Events:
11th Annual LifeSci Partners Corporate Access Event 2022
Wednesday, January 5 – Friday, January 7
Registration and to submit 1x1 meeting requests: LifeSci Partners Corporate Access Event 2022
H.C. Wainwright Virtual BioConnect 2022 Conference
Monday, January 10 – Thursday, January 13
A webcast of Mr. Tucker’s presentation will be available on-demand as of 7am EST, Monday, January 10.
A replay of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.
About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com
Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.